Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry

Forensic Science International

Volumn 188, Issue 1-3, 2009, Pages 144-151

  Concheiro, Marta ^a   Shakleya, Diaa M ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Buprenorphine; Ion trap; LCMS; Umbilical cord

Indexed keywords

BUPRENORPHINE; GLUCURONIDE; NORBUPRENORPHINE; OPIATE;

ARTICLE; ASSAY; EXTRACTION; FEMALE; HUMAN; ION MONITORING; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; UMBILICAL CORD;

BUPRENORPHINE; CHROMATOGRAPHY, LIQUID; FEMALE; FORENSIC TOXICOLOGY; GLUCURONIDES; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PREGNANCY; TANDEM MASS SPECTROMETRY; UMBILICAL CORD;

EID: 67349185119     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.04.005     Document Type: Article

References (50)

1. D'Apolito K. Substance abuse: infant and childhood outcomes. J. Pediatr. Nurs. 13 (1998) 307-316
2. Smith L.M., LaGasse L.L., Derauf C., Grant P., Shah R., Arria A., Huestis M., Haning W., Strauss A., Della Grotta S., Liu J., and Lester B.M. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118 (2006) 1149-1156
3. Lozano J., Garcia-Algar O., Vall O., de la Torre R., Scaravelli G., and Pichini S. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther. Drug Monit. 29 (2007) 711-734
4. Gray T., and Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal. Bioanal. Chem. 388 (2007) 1455-1465
5. Kintz P., and Mangin P. Determination of gestational opiate, nicotine, benzodiazepine, cocaine and amphetamine exposure by hair analysis. J. Forensic Sci. Soc. 33 (1993) 139-142
6. Goodwin R.S., Wilkins D.G., Averin O., Choo R.E., Schroeder J.R., Jasinski D.R., Johnson R.E., Jones H.E., and Huestis M.A. Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin. Chem. 53 (2007) 2136-2143
7. Kelly T., Gray T.R., and Huestis M.A. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of ten amphetamine-, methamphetamine- and 3,4-methylenediozymethamphetamine-related (MDMA) analytes in human meconium. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 867 (2008) 194-204
8. Gray T.R., Shakleya D.M., and Huestis M.A. Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography tandem mass spectrometry. J. Chromatogr. B 863 (2008) 107-114
9. Kacinko S.L., Shakleya D.M., and Huestis M.A. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Anal. Chem. 80 (2008) 246-252
10. Choo R.E., Murphy C.M., Jones H.E., and Huestis M. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine,2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. J. Chromatogr. B 814 (2005) 369-373
11. Montgomery D., Plate C., Alder S.C., Jones M., Jones J., and Christensen R.D. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J. Perinatol. 26 (2006) 11-14
12. Montgomery D.P., Plate C.A., Jones M., Jones J., Rios R., Lambert D.K., Schumtz N., Wiedmeier S.E., Burnett J., Ail S., Brandel D., Maichuck G., Durham C.A., Henry E., and Christensen R.D. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J. Perinatol. 28 (2008) 750-753
13. Drug Addiction Treatment Act of 2000, 2000, p. 111, STAT. 1101.
14. Lejeune C., Simmat-Durand L., Gourarier L., and Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend. 82 (2006) 250-257
15. Fischer G. Treatment of opioid dependence in pregnant women. Addiction 95 (2000) 1141-1144
16. Dunlop A., Panjari M., O'Sullivan H., Henschke P., Love V., Ritter A., and Lintzeris N. Clinical Guidelines for the use of Buprenorphine in Pregnancy (2003), Turning Point Alcohol and Drug Centre, Fitzroy
17. Jones H.E., Johnson R.E., Jasinski D.R., O'Grady K E., Chisholm C.A., Choo R.E., Crocetti M., Dudas R., Harrow C., Huestis M.A., Jansson L.M., Lantz M., Lester B.M., and Milio L. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 79 (2005) 1-10
18. Marquet P. Pharmacology of high-dose buprenorphine. In: Kintz P., and Marquet P. (Eds). Buprenorphine Therapy of Opiate Addiction (2002), Humana Press, Totowa, NJ 1-11
19. Kobayashi K., Tamamoto T., Chiba K., Tani M., Shimada N., Ishizaki T., and Kuroiwa Y. Human buprenorphine n-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab. Dispos. 26 (1998) 818-821
20. Hegstad S., Khiabani H.Z., Oiestad E.L., Berg T., and Christophersen A.S. Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS. J. Anal. Toxicol. 31 (2007) 214-219
21. Kronstrand R., Selden T.G., and Josefsson M. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 27 (2003) 464-470
22. Cirimele V., Etienne S., Villain M., Ludes B., and Kintz P. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Forensic Sci. Int. 143 (2004) 153-156
23. Cirimele V., Kintz P., Lohner S., and Ludes B. Enzyme immunoassay validation for the detection of buprenorphine in urine. J. Anal. Toxicol. 27 (2003) 103-105
24. Huang W., Moody D.E., and McCance-Katz E.F. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry. Ther. Drug Monit. 28 (2006) 245-251
25. Tracqui A., Kintz P., and Mangin P. HPLC-MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J. Forensic Sci. 42 1 (1997) 111-114
26. Miller E.I., Torrance H.J., and Oliver J.S. Validation of the immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine. J. Anal. Toxicol. 30 (2006) 115-119
27. Favretto D., Frison G., Vogliardi S., and Ferrara S.D. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun. Mass Spectrom. 20 (2006) 1257-1265
28. Liu A.C., Lin T.Y., Su L.W., and Fuh M.R. Online solid-phase extraction liquid chromatography-electrospray-tandem mass spectrometry analysis of buprenorphine and three metabolites in human urine. Talanta 75 (2008) 198-204
29. Hull M.J., Bierer M.F., Griggs D.A., Long W.H., Nixon A.L., and Flood J.G. Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay. J. Anal. Toxicol. 32 (2008) 516-521
30. Kacinko S., Concheiro-Guisan M., Shakleya D., and Huestis M. Development and validation of a liquid chromatography-tandem mass spectrometric assay for the simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine. Anal. Bioanal. Chem. 392 (2008) 903-911
31. Rodriguez-Rosas M.E., Lofwall M.R., Strain E.C., Siluk D., and Wainer I.W. Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 850 (2007) 538-543
32. Musshoff F., Trafkowski J., Kuepper U., and Madea B. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J. Mass Spectrom. 41 (2006) 633-640
33. Ceccato A., Klinkenberg R., Hubert P., and Streel B. Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry. J. Pharm. Biomed. Anal. 32 (2003) 619-631
34. Polettini A., and Huestis M.A. Simultaneous determination of buprenorphine, norburpennorphine, and buprenorphine-glucuronide in plasma by liquid charmatography-tandem mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 754 (2001) 447-459
35. Moody D.E., Laycock J.D., Spanbauer A.C., Crouch D.J., Foltz R.L., Josephs J.L., Amass L., and Bickel W.K. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21 (1997) 406-411
36. Murphy C.M., and Huestis M.A. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-d-glucuronide and norbuprenorphine-3-beta-d-glucuronide in human plasma. J. Mass Spectrom. 40 (2005) 70-74
37. Scislowski M., Piekoszewski W., Kamenczak A., and Florek E. Simultaneous determination of buprenorphine and norbuprenorphine in serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry. J. Anal. Toxicol. 29 (2005) 249-253
38. Hoja H., Marquet P., Verneuil B., Lotfi H., Dupuy J.L., and Lachatre G. Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 21 (1997) 160-165
39. Wilkins D.G., Rollins D.E., Valdez A.S., Mizuno A., Krueger G.C., and Cone E.J. A retrospective study of buprenorphine and norbuprenorphine in human hair after multiple doses. J. Anal. Toxicol. 23 (1999) 409-415
40. Kintz P. Determination of buprenorphine and its dealkylated metabolite in human hair. J. Anal. Toxicol. 17 (1993) 443-444
41. Thieme D., Sachs H., and Thevis M. Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass spectrometry. J. Mass Spectrom. 43 (2008) 974-979
42. Kintz P., Tracqui A., Mangin P., and Edel Y. Sweat testing in opioid users with a sweat patch. J. Anal. Toxicol. 20 (1996) 393-397
43. Grimm D., Pauly E., Poschl J., Linderkamp O., and Skopp G. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Ther. Drug Monit. 27 (2005) 526-530
44. Moore C.M., Brown S., Negrusz A., Tebbett I., Meyer W., and Jain L. Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: a case study. J. Anal. Toxicol. 17 (1993) 62
45. Le N.L., Reiter A., Tomlinson K., Jones J., and Moore C. The detection of oxycodone in meconium specimens. J. Anal. Toxicol. 29 (2005) 54-57
46. Winecker R.E., Goldberger B.A., Tebbett I., Behnke M., Eyler F.D., Conlon M., Wobie K., Karlix J., and Bertholf R.L. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J. Anal. Toxicol. 21 (1997) 97-104
47. Krouwer J.S., and Rabinowitz R. How to improve estimates of imprecision. Clin. Chem. 30 (1984) 290-292
48. European Union Decision 2002/657/EC (17/8/2002). Off. J. Eur. Commun. 221 (2002) 8-36
49. Sauvage F.L., Gaulier J.M., Lachatre G., and Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin. Chem. 54 (2008) 1519-1527
50. Kacinko S., Jones H., Johnson R., Choo R., and Huestis M. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin. Pharmacol. Ther. 84 5 (2008) 604-612